ConductScience.org, home

Paper34201872

The Stimulating Effect of Rosmarinic Acid and Extracts from Rosemary and Lemon Balm on Collagen Type I Biosynthesis in Osteogenesis Imperfecta Type I Skin Fibroblasts.

Sutkowska J and 6 others. Pharmaceutics, 2021. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. The Stimulating Effect of Rosmarinic Acid and Extracts from Rosemary and Lemon Balm on Collagen Type I Biosynthesis in Osteogenesis Imperfecta Type I Skin Fibroblasts. Papers, record 34201872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34201872

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Stimulating Effect of Rosmarinic Acid and Extracts from Rosemary and Lemon Balm on Collagen Type I Biosynthesis in Osteogenesis Imperfecta Type I Skin Fibroblasts.
PubMed
Journal
Pharmaceutics
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2021-07-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
the project № POWR.03.02.00-00-I051/16 from European Union funds , PO WER 2014-2020, grant № 11/IMSD/G/2019.European Union fundsPubMed

Source PubMed

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133285594Rosmarinic Acid-Human Pharmacokinetics and Health Benefits.Planta Med2021https://conductscience.org/library/papers/33285594PubMed
216061337Flavonoid composition and antimicrobial activity of Cirsium rivulare (Jacq.) All. flowers.J Ethnopharmacol2005https://conductscience.org/library/papers/16061337PubMed
327210890Rosmarinic acid inhibits poly(I:C)-induced inflammatory reaction of epidermal keratinocytes.Life Sci2016https://conductscience.org/library/papers/27210890PubMed
421835416
Comparison of different extraction procedures for the comprehensive characterization of bioactive phenolic compounds in Rosmarinus officinalis by reversed-phase high-performance liquid chromatography with diode array detection coupled to electrospray time-of-flight mass spectrometry.
J Chromatogr A2011https://conductscience.org/library/papers/21835416PubMed
525978046Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid in Healthy Individuals: A Randomized Controlled Trial.PLoS One2015https://conductscience.org/library/papers/25978046PubMed
625963598Molecular Outcome, Prediction, and Clinical Consequences of Splice Variants in COL1A1, Which Encodes the proα1(I) Chains of Type I Procollagen.Hum Mutat2015https://conductscience.org/library/papers/25963598PubMed
726478226Osteogenesis Imperfecta Type I Caused by COL1A1 Deletions.Calcif Tissue Int2016https://conductscience.org/library/papers/26478226PubMed
832184728A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases.Front Pharmacol2020https://conductscience.org/library/papers/32184728PubMed
917982699Stimulation of collagen biosynthesis by flavonoid glycosides in skin fibroblasts of osteogenesis imperfecta type I and the potential mechanism of their action.Int J Mol Med2007https://conductscience.org/library/papers/17982699PubMed
1032797291Osteogenesis imperfecta-pathophysiology and therapeutic options.Mol Cell Pediatr2020https://conductscience.org/library/papers/32797291PubMed
1128367927Beneficial Effects of Lemon Balm Leaf Extract on In Vitro Glycation of Proteins, Arterial Stiffness, and Skin Elasticity in Healthy Adults.J Nutr Sci Vitaminol (Tokyo)2017https://conductscience.org/library/papers/28367927PubMed
1230106978Cytotoxicity of white birch bud extracts: Perspectives for therapy of tumours.PLoS One2018https://conductscience.org/library/papers/30106978PubMed
137942841Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen.Am J Hum Genet1994https://conductscience.org/library/papers/7942841PubMed
1431903662Review of the safety of application of cosmetic products containing parabens.J Appl Toxicol2020https://conductscience.org/library/papers/31903662PubMed
1530847003Phytochemicals Rosmarinic Acid, Ampelopsin, and Amorfrutin-A Can Modulate Age-Related Phenotype of Serially Passaged Human Skin Fibroblasts in vitro.Front Genet2019https://conductscience.org/library/papers/30847003PubMed
1632532056Anticancer Activity of Rosmarinus officinalis L.: Mechanisms of Action and Therapeutic Potentials.Nutrients2020https://conductscience.org/library/papers/32532056PubMed
1727167460Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology.J Ethnopharmacol2016https://conductscience.org/library/papers/27167460PubMed
1820825192Characterization of phenolic composition in Lamiaceae spices by LC-ESI-MS/MS.J Agric Food Chem2010https://conductscience.org/library/papers/20825192PubMed
1923749111UV radiation and the skin.Int J Mol Sci2013https://conductscience.org/library/papers/23749111PubMed
2032455585Rosemary (Rosmarinus officinalis L., syn Salvia rosmarinus Spenn.) and Its Topical Applications: A Review.Plants (Basel)2020https://conductscience.org/library/papers/32455585PubMed

See all 52 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42943331The Network Pharmacology of Rosmarinic Acid and Elucidating the Wound Healing Potential of a Rosmarinic Acid-Enriched Trachystemon orientalis Extract.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943331PubMed
42720075Comparative Phytochemical and Biological Evaluation of Four Thymus Species From Türkiye for Dermocosmetic Applications.Chem Biodivers2026https://conductscience.org/library/papers/42720075PubMed
41901225Rosemary Aqueous Extract as a Natural Alternative to Retinol for Skin Aging Intervention.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901225PubMed
40942033Evaluation of Salvia yangii Extract as a Promising Protective Raw Material Applied Topically to the Skin.Molecules2025https://conductscience.org/library/papers/40942033PubMed
40362239Skin Photoprotection and Anti-Aging Benefits of a Combination of Rosemary and Grapefruit Extracts: Evidence from In Vitro Models and Human Study.Int J Mol Sci2025https://conductscience.org/library/papers/40362239PubMed
40298643Natural Compounds with Beneficial Effects on Skin Collagen Type I and Mechanisms of Their Action.Antioxidants (Basel)2025https://conductscience.org/library/papers/40298643PubMed
40135177Reversing Oxinflammation Associated with Glycative Stress and Formation of Advanced Glycation End Products with a Dietary Supplement Containing Rosemary Extract.J Clin Aesthet Dermatol2025https://conductscience.org/library/papers/40135177PubMed
40135175A Single-center, Double-blinded, Randomized, Placebo-controlled Trial Evaluating the Safety and Efficacy of a Dietary Supplement Containing Rosemary Extract on Visible Facial Skin Quality.J Clin Aesthet Dermatol2025https://conductscience.org/library/papers/40135175PubMed
40078862Reversing Glycation with a Dietary Supplement Containing Rosemary Extract.J Clin Aesthet Dermatol2025https://conductscience.org/library/papers/40078862PubMed
38956573Optimization of the extraction process for Shenshou Taiyi powder based on Box-Behnken experimental design, standard relation, and FAHP-CRITIC methods.BMC Complement Med Ther2024https://conductscience.org/library/papers/38956573PubMed
37513476Modulatory Effect of Rosmarinic Acid on H2O2-Induced Adaptive Glycolytic Response in Dermal Fibroblasts.Molecules2023https://conductscience.org/library/papers/37513476PubMed
36142253Rosemary Extract-Induced Autophagy and Decrease in Accumulation of Collagen Type I in Osteogenesis Imperfecta Skin Fibroblasts.Int J Mol Sci2022https://conductscience.org/library/papers/36142253PubMed
35391712Biomedical features and therapeutic potential of rosmarinic acid.Arch Pharm Res2022https://conductscience.org/library/papers/35391712PubMed
34768882The Beneficial Effect of Rosmarinic Acid on Benzophenone-3-Induced Alterations in Human Skin Fibroblasts.Int J Mol Sci2021https://conductscience.org/library/papers/34768882PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34201872

GET https://conductscience.org/api/papers/v1/34201872/references?page=2